Opendata, web and dolomites


Miniaturised optically accessible bioreactor for drug discovery and biological research

Total Cost €


EC-Contrib. €






 MOAB project word cloud

Explore the words cloud of the MOAB project. It provides you a very rough idea of what is the project "MOAB" about.

extended    integrating    populations    covered    discovery    medium    dish    frame    patent    cultured    suitable    occurring    strategy    continuous    modified    96    animal    obsolete    poc    companies    anymore    agents    subjected    animals    valorising    culture    radically    flat    cancer    patients    vivo    fluid    clinical    efficacy    accessible    demonstrations    actionable    optically    pathologies    therapeutic    ten    originated    organoids    accommodate    few    dimensions    lasts    perfusion    stem       neurodegeneration    single    context    time    moab    diagnostics    interactions    cell    substrate    nichoid    pct    chamber    tested    identification    pharmaceutical    vitro    size    nano    regulatory    added    billion    approvals    patents    market    feasibility    inventions    ipr       commercial    patterned    post    dynamics    infusion    grant    italian    bioreactor    erc    consolidator    miniaturised    99    confirmed    lab    original    trial    cultivation    fact    device    millimetres    3d    perform    move    drug    measured    drugs    cog   

Project "MOAB" data sheet

The following table provides information about the project.


Organization address
city: MILANO
postcode: 20133

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-PoC
 Funding Scheme ERC-POC
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2020-05-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    POLITECNICO DI MILANO IT (MILANO) coordinator 105˙000.00


 Project objective

The problem that we address is that the pharmaceutical companies do not develop radically new drugs anymore, because the development process lasts ten years and costs around one billion euro. Development of a new drug is subjected to regulatory approvals following three demonstrations: lab discovery in vitro, animal testing in vivo and clinical trial on patients. This process has 99.9% overall failure, of which 96.4% because the drug efficacy measured in vitro is not confirmed in animals. In fact, the most widespread technology used to test therapeutic agents in vitro, a flat culture dish in which single cell populations are cultured and the drug to be tested is added to the culture, is obsolete. In many pathologies such as cancer and neurodegeneration, in vivo response to drugs is based on complex interactions, occurring in three-dimensions (3D) between several cell populations. To solve this problem, in the context of an ERC consolidator grant (CoG) that I currently lead, I integrated a novel nano-patterned 3D substrate for stem cell culture, called the “nichoid”, into an existing miniaturised optically accessible bioreactor (MOAB). The MOAB allows to culture 3D organoids of few millimetres in size, under continuous perfusion of the culture medium, infusion of the drug to be tested and diagnostics of cell response both in real time and also post-cultivation. Both the original inventions (the nichoid and the MOAB) are covered by Italian patents originated in the frame of the CoG project and already extended as PCT. The goal of this PoC proposal is to perform a technical and commercial feasibility to move to the market the MOAB device integrating the nichoid-patterned substrate. I will characterize the fluid-dynamics of the bioreactor chamber that has been modified to accommodate the nichoid substrate. Also, I will set a market assessment and an actionable IPR strategy with identification of a suitable exploitation strategy for valorising the patent/know how.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOAB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOAB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

DINEMOS (2019)

Discovery of New Molecular Semiconductors

Read More  


Theoretical developments for precision spectroscopy of polyatomic and polyelectronic molecules

Read More  

MitoRepairosome (2020)

Dissecting the mechanism of DNA repair in human mitochondria

Read More